UBS Group Analysts Give Lanxess (ETR:LXS) a €53.00 Price Target

UBS Group set a €53.00 ($61.63) target price on Lanxess (ETR:LXS) in a research report report published on Tuesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

LXS has been the topic of a number of other reports. DZ Bank reaffirmed a neutral rating on shares of Lanxess in a report on Tuesday, August 6th. Nord/LB set a €53.00 ($61.63) target price on Lanxess and gave the stock a neutral rating in a report on Friday, August 2nd. Barclays set a €55.00 ($63.95) target price on Lanxess and gave the stock a neutral rating in a report on Thursday, August 8th. Deutsche Bank set a €70.00 ($81.40) target price on Lanxess and gave the stock a buy rating in a report on Monday, August 5th. Finally, JPMorgan Chase & Co. set a €60.00 ($69.77) price target on Lanxess and gave the company a buy rating in a research report on Friday, August 2nd. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and eight have assigned a buy rating to the stock. Lanxess currently has a consensus rating of Hold and a consensus price target of €60.92 ($70.84).

ETR:LXS opened at €50.14 ($58.30) on Tuesday. The business’s 50-day moving average price is €53.46 and its 200 day moving average price is €50.06. The firm has a market cap of $4.55 billion and a P/E ratio of 11.53. Lanxess has a 52-week low of €39.47 ($45.90) and a 52-week high of €70.66 ($82.16). The company has a quick ratio of 1.51, a current ratio of 2.72 and a debt-to-equity ratio of 107.55.

Lanxess Company Profile

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

See Also: Reverse Stock Split

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit